Published online before print February 11, 2008, doi: 10.1161/CIRCULATIONAHA.107.743963
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:1283-1291.)
© 2008 American Heart Association, Inc.
Imaging |
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
From Emory University School of Medicine, Atlanta, Ga (L.J.S., E.V.); Cedars-Sinai Medical Center, Los Angeles, Calif (D.S.B., S.W.H., J.F., P.S., G. Germano); Vanderbilt University Medical Center, Nashville, Tenn (D.J.M.); Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada (G.B.J.M.); Veterans Affairs Cooperative Studies Program Coordinating Center, Veterans Affairs Connecticut Healthcare System, West Haven (P.M.H.); Christiana Care Health System, Newark, Del (W.S.W.); South Texas Veterans Health Care System, San Antonio, Tex (R.A.O., G.V.H.); Hartford Hospital, Hartford, Conn (M.D.); Mid America Heart Institute/University of Missouri–Kansas City, Kansas City, Mo (J.A.S., B.M.); St Louis University, St Louis, Mo (B.R.C.); Montreal Heart Institute, Montreal, Quebec, Canada (G. Gosselin); Geisinger Clinic, Danville, Pa (P.B.); London Health Sciences Centre, London, Ontario, Canada (W.J.K.); University of Rochester, Rochester, NY (R.G.S.); Foothills Hospital, Calgary, Alberta, Canada (M.K.); University of Michigan, Ann Arbor (E.R.B.); McMaster University, Hamilton, Ontario, Canada (K.K.T.); and Western New York Veterans Affairs Healthcare Network/Buffalo General Hospital/State University of New York, Buffalo (W.E.B.).
Correspondence to Leslee J. Shaw, PhD, Suite 1-N, 1256 Briarcliff Rd NE, EPICORE, Emory University, Atlanta, GA 30306. E-mail leslee.shaw{at}emory.edu
Received October 3, 2007; accepted January 8, 2008.
Background— Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the effectiveness of percutaneous coronary intervention (PCI) for ischemia reduction added to optimal medical therapy (OMT) with the use of myocardial perfusion single photon emission computed tomography (MPS).
Methods and Results— Of the 2287 COURAGE patients, 314 were enrolled in this substudy of serial rest/stress MPS performed before treatment and 6 to 18 months (mean=374±50 days) after randomization using paired exercise (n=84) or vasodilator stress (n=230). A blinded core laboratory analyzed quantitative MPS measures of percent ischemic myocardium. Moderate to severe ischemia encumbered 
10% myocardium. The primary end point was 5% reduction in ischemic myocardium at follow-up. Treatment groups had similar baseline characteristics. At follow-up, the reduction in ischemic myocardium was greater with PCI+OMT (–2.7%; 95% confidence interval, –1.7%, –3.8%) than with OMT (–0.5%; 95% confidence interval, –1.6%, 0.6%; P<0.0001). More PCI+OMT patients exhibited significant ischemia reduction (33% versus 19%; P=0.0004), especially patients with moderate to severe pretreatment ischemia (78% versus 52%; P=0.007). Patients with ischemia reduction had lower unadjusted risk for death or myocardial infarction (P=0.037 [risk-adjusted P=0.26]), particularly if baseline ischemia was moderate to severe (P=0.001 [risk-adjusted P=0.08]). Death or myocardial infarction rates ranged from 0% to 39% for patients with no residual ischemia to 10% residual ischemia on follow-up MPS (P=0.002 [risk-adjusted P=0.09]).
Conclusions— In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone. Our findings suggest a treatment target of 5% ischemia reduction with OMT with or without coronary revascularization.
CLINICAL PERSPECTIVE
Related Article:
-
Clinical Summaries
Circulation 2008 117: 1247.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  O. Gaemperli, L. Husmann, T. Schepis, P. Koepfli, I. Valenta, W. Jenni, H. Alkadhi, T. F. Luscher, and P. A. Kaufmann Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? Eur. Heart J., December 1, 2009; 30(23): 2921 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cassar, D. R. Holmes Jr, C. S. Rihal, and B. J. Gersh Chronic Coronary Artery Disease: Diagnosis and Management Mayo Clin. Proc., December 1, 2009; 84(12): 1130 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, and A. E. Iskandrian A Study of the Effects of Ranolazine Using Automated Quantitative Analysis of Serial Myocardial Perfusion Images J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1301 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J Sung and N-Y Chan Practice viewpoints: AICD, who and when? Heart Asia, October 15, 2009; 2009(10): 7 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Moses, M. B. Leon, and G. W. Stone Left Main Percutaneous Coronary Intervention Crossing the Threshold: Time for a Guidelines Revision! J. Am. Coll. Cardiol., October 13, 2009; 54(16): 1512 - 1514. [Full Text] [PDF]
|
|
|
|
|
|
W. Wijns and P. Kolh Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon Eur. Heart J., September 2, 2009; 30(18): 2182 - 2185. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Uebleis, A. Becker, I. Griesshammer, P. Cumming, C. Becker, M. Schmidt, P. Bartenstein, and M. Hacker Stable Coronary Artery Disease: Prognostic Value of Myocardial Perfusion SPECT in Relation to Coronary Calcium Scoring--Long-term Follow-up Radiology, September 1, 2009; 252(3): 682 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bourque, B. H. Holland, D. D. Watson, and G. A. Beller Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role? J. Am. Coll. Cardiol., August 4, 2009; 54(6): 538 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Shaw and J. Narula Risk Assessment and Predictive Value of Coronary Artery Disease Testing J. Nucl. Med., August 1, 2009; 50(8): 1296 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sarno, I. Decraemer, P. K. Vanhoenacker, B. De Bruyne, M. Hamilos, T. Cuisset, E. Wyffels, J. Bartunek, G. R. Heyndrickx, and W. Wijns On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization: A Comparison With Invasive Angiography J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Berman and J. K. Min Can Coronary Computed Tomographic Angiography Trigger Coronary Revascularization?: Questioning the Appropriateness of the Question J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 558 - 560. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Giugliano, J. A. White, C. Bode, P. W. Armstrong, G. Montalescot, B. S. Lewis, A. van `t Hof, L. G. Berdan, K. L. Lee, J. T. Strony, et al. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2176 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography? J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Min and D. Berman Anatomic and Functional Assessment of Coronary Artery Disease: Convergence of 2 Aims in a Single Setting Circ Cardiovasc Imaging, May 1, 2009; 2(3): 163 - 165. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A A Fox COURAGE to change practice? Revascularisation in patients with stable coronary artery disease Heart, May 1, 2009; 95(9): 689 - 692. [Full Text] [PDF]
|
|
|
|
|
|
E. Nagel Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 434 - 436. [Full Text] [PDF]
|
|
|
|
|
|
T Chua The evolving role of molecular imaging for coronary artery disease: where do we stand today? Heart Asia, March 6, 2009; 2009(2): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Husmann, B. A. Herzog, O. Gaemperli, F. Tatsugami, N. Burkhard, I. Valenta, P. Veit-Haibach, C. A. Wyss, U. Landmesser, and P. A. Kaufmann Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating Eur. Heart J., March 1, 2009; 30(5): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stirrup, K. Wechalekar, A. Maenhout, and C. Anagnostopoulos Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes Br. Med. Bull., March 1, 2009; 89(1): 63 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Neglia and A. L'Abbate Myocardial Perfusion Reserve in Ischemic Heart Disease J. Nucl. Med., February 1, 2009; 50(2): 175 - 177. [Full Text] [PDF]
|
|
|
|
|
|
P. A.L. Tonino, B. De Bruyne, N. H.J. Pijls, U. Siebert, F. Ikeno, M. van `t Veer, V. Klauss, G. Manoharan, T. Engstrom, K. G. Oldroyd, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention N. Engl. J. Med., January 15, 2009; 360(3): 213 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Ellis Refining the Art and Science of Coronary Stenting N. Engl. J. Med., January 15, 2009; 360(3): 292 - 294. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The year in cardiac imaging. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70. [Full Text] [PDF]
|
|
|
|
|
|
M. A de Belder and L. Hamilton Evaluating risks and benefits in coronary revascularisation--a very imperfect art? Heart, January 1, 2009; 95(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Joshi Letter by Joshi Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e838 - e838. [Full Text] [PDF]
|
|
|
|
|
|
G. Tarantini, R. Razzolini, and S. Iliceto Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e839 - e839. [Full Text] [PDF]
|
|
|
|
|
|
L. J. Shaw, E. Veledar, D. S. Berman, S. W. Hayes, J. Friedman, P. Slomka, G. Germano, D. J. Maron, G. B. J. Mancini, P. M. Hartigan, et al. Response to Letters Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e840 - e841. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons Noninvasive Diagnosis and Prognosis Assessment in Chronic Coronary Artery Disease: Stress Testing With and Without Imaging Perspective Circ Cardiovasc Imaging, November 1, 2008; 1(3): 257 - 269. [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Lin, R. A. Dudley, F. L. Lucas, D. J. Malenka, E. Vittinghoff, and R. F. Redberg Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention JAMA, October 15, 2008; 300(15): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Diamond and S. Kaul The Disconnect Between Practice Guidelines and Clinical Practice--Stressed Out JAMA, October 15, 2008; 300(15): 1817 - 1819. [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad and B. J. Gersh Should Percutaneous Revascularization for Stable Coronary Artery Disease Be Performed Sooner or Later? J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 480 - 482. [Full Text] [PDF]
|
|
|
|
|
|
D. G. Katritsis and B. Meier Percutaneous Coronary Intervention for Stable Coronary Artery Disease J. Am. Coll. Cardiol., September 9, 2008; 52(11): 889 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schomig, J. Mehilli, A. de Waha, M. Seyfarth, J. Pache, and A. Kastrati A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease J. Am. Coll. Cardiol., September 9, 2008; 52(11): 894 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Kirtane and D. J. Cohen When Is Better Not Good Enough?: Insights From the COURAGE Economic Study Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 4 - 6. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Weintraub, W. E. Boden, Z. Zhang, P. Kolm, Z. Zhang, J. A. Spertus, P. Hartigan, E. Veledar, C. Jurkovitz, J. Bowen, et al. Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 12 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Peterson and J. S. Rumsfeld Finding the Courage to Reconsider Medical Therapy for Stable Angina N. Engl. J. Med., August 14, 2008; 359(7): 751 - 753. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Zoghbi, T. A. Dorfman, and A. E. Iskandrian The Effects of Medications on Myocardial Perfusion J. Am. Coll. Cardiol., August 5, 2008; 52(6): 401 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Holmes Jr and D. O. Williams Catheter-Based Treatment of Coronary Artery Disease: Past, Present, and Future Circ Cardiovasc Interv, August 1, 2008; 1(1): 60 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Percutaneous Coronary Intervention Reduces Ischemia in COURAGE Substudy Journal Watch Cardiology, April 30, 2008; 2008(430): 3 - 3. [Full Text]
|
|